authors
- Rosen, Jeffrey B
- Ballantyne, Christie M
- Hsueh, Willa A
- Lin, Jianxin
- Shah, Arvind K
- Lowe, Robert S
- Tershakovec, Andrew M
Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2015
published in
- Lipids in health and disease Journal
has subject area
- Aged
- Anticholesteremic Agents
- Atorvastatin
- Blood Glucose
- Blood Pressure
- C-Reactive Protein
- Cholesterol, LDL
- Coronary Artery Disease
- Coronary Disease
- Double-Blind Method
- Ezetimibe
- Female
- Humans
- Hypercholesterolemia
- Insulin Resistance
- Lipoproteins, HDL
- Male
- Metabolic Syndrome
- Middle Aged
- Obesity, Abdominal
- Risk Factors
- Simvastatin
- Treatment Outcome
- Triglycerides